Status:

COMPLETED

The Surrogate Project (Surrogate Storytelling)

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

Icahn School of Medicine at Mount Sinai

Conditions:

Surrogate Decision Maker, After Death of Patient

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

Research Protocol Abstract: This is a phase II controlled trial (RCT) of a "storytelling" intervention compared to no treatment among surrogates who have participated in a decision to limit life-sust...

Eligibility Criteria

Inclusion

  • Screening/Re-contact (1st phase)
  • Eligible patients will:
  • lack decision-making capacity
  • have a surrogate decision maker (family member or friend)
  • Eligible surrogates will:
  • be 18 years of age or older
  • self-identify as having primary decision-making authority for the patient
  • live within approximately 50miles or less of the University of Pittsburgh
  • be able to conduct a 1hr interview in English
  • Court-appointed power of attorney will be excluded, as they are not expected to experience the same emotional distress as a family member or friend of a critically ill patient.
  • For Assignment to Intervention/Control (2nd phase)
  • Eligible surrogates will:
  • have previously given consent for study staff to follow their loved one's course in the hospital and to be re-contacted
  • have participated in decision making about limitation of life-sustaining treatments (LST) for their loved one (ICU patient)
  • have had their loved one (ICU patient) die in the hospital

Exclusion

  • Screening/Re-contact
  • Ineligible patients will:
  • be less than 18 years old
  • prisoners
  • be of other legal concern, such as malpractice
  • Ineligible surrogates will:
  • be less than 18 years old
  • be unable to complete a 1-hour interview and questionnaires in English
  • For Assignment to Intervention/Control
  • Ineligible patients will:
  • have fully and permanently regained decision-making capacity and therefore no longer require a surrogate to make treatment decisions
  • be discharged from hospital alive

Key Trial Info

Start Date :

June 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2014

Estimated Enrollment :

115 Patients enrolled

Trial Details

Trial ID

NCT01902784

Start Date

June 1 2013

End Date

November 1 2014

Last Update

June 15 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States, 15213